TFXNYSESurgical & Medical Instruments & ApparatusUS GAAP · USD

Teleflex Incorporated

Teleflex Inc. is a U.S.-based medical technology company that designs, manufactures, and supplies single-use devices used in critical care, surgical, and diagnostic procedures. Its portfolio serves hospitals and healthcare providers worldwide through direct sales and distributors, with manufacturing and operations spread across North America, Europe, and Asia.

Ask about the company
Revenue569m USD
−81.3 %y/y
Operating profit (EBIT)13.9m USD
−90.8 %y/y
EBIT margin2.4%
−2.5 ppy/y
Net income-714m USD
−1,125.2 %y/y

Fiscal year 2025 · change from previous year

Development 2020–2025

01,0002,0003,0004,000m USD2020: 711 m USD2020: EBIT 95 m USD20202021: 2,810 m USD2021: EBIT 628 m USD20212022: 2,791 m USD2022: EBIT 500 m USD20222023: 2,974 m USD2023: EBIT 506 m USD20232024: 3,047 m USD2024: EBIT 151 m USD20242025: 569 m USD2025: EBIT 14 m USD202556914
RevenueOperating profit (EBIT)
Ask Clarifo about Teleflex Incorporated

Business

Share of revenue
Critical care devices30 %

Single-use products used in intensive care and emergent hospital procedures.

Surgical and diagnostic devices25 %

Devices used in common surgical and diagnostic procedures across hospitals.

Vascular access and catheters20 %

Catheters, access devices, and related products for interventional care.

Anesthesia and respiratory care15 %

Products supporting airway management, anesthesia, and breathing support.

OEM and specialty products10 %

Specialty-engineered and original equipment manufacturer products and components.

Products

Reported · share of revenue
46.1%32.5%21.0%FY2025100 %
  • Vascular Access46.1 %
  • Interventional32.5 %
  • Surgical21.0 %
  • Other0.5 %

Source: 10-K FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.

Customers

Teleflex sells primarily to hospitals, healthcare systems, and other healthcare providers that use its devices in critical care and surgical settings. It also serves distributors and, in some product lines, original equipment and specialty channel customers. Demand is tied to procedure volumes, clinical adoption, reimbursement conditions, and the need for reliable single-use devices.

Hospitals and health systems

Buy single-use devices for critical care, surgery, and diagnostic procedures.

Healthcare providers and clinics

Purchase procedure-specific devices used across inpatient and outpatient care.

Distributors

Resell Teleflex products in markets where indirect channel coverage is needed.

OEM and specialty customers

Buy selected product lines or components for integration into broader offerings.

Strategy

Teleflex’s strategy centers on expanding its product portfolio, developing new products and line extensions, and broadening use of its technologies into new markets. The company also emphasizes manufacturing efficiency, selective acquisitions and partnerships, and portfolio optimization to strengthen its competitive position in hospital-based medical devices.

New product developmentMedium term

Fresh products and line extensions support share gains in procedure-based markets.

Geographic expansionMedium term

Entering new markets reduces dependence on any one region or procedure mix.

Operational efficiencyShort term

Lower-cost manufacturing and distribution improve competitiveness in commoditized categories.

Portfolio optimizationMedium term

Divesting non-core businesses can sharpen focus on higher-priority medical device lines.

Geography

Teleflex sells worldwide and reports operating segments for the Americas, EMEA, and Asia Pacific. Manufacturing is concentrated in the Czech Republic, Malaysia, Mexico, and the United States, which supports a global supply chain but also creates exposure to cross-border logistics, currency movements, and regional procurement policies.

Risks

Teleflex faces intense competition, product liability exposure, and regulatory risk because its devices are used in high-acuity clinical settings. It is also exposed to reimbursement pressure, supply chain disruption, cybersecurity risk, and foreign exchange or procurement-related pricing pressure in international markets.

Sorted by severity
LowMediumHighLowMediumHighImpact →Likelihood →Product liability and recall exposure1Intense medical device competition2Reimbursement and coverage pressure3Cybersecurity and IT disruption4Foreign exchange and procurement policy risk5
Impact is the risk’s severity and likelihood how probable it is over the next few years, both assessed from the company’s reports. Numbers match the list.
  1. Product liability and recall exposureImpact: CriticalLikelihood: Medium

    Devices used on seriously ill patients can trigger claims if defects or labeling issues arise.

    ExposureCritical careSurgicalImplanted or invasive products
  2. Intense medical device competitionImpact: HighLikelihood: Medium

    Large and niche competitors can outspend Teleflex on development, marketing, and distribution.

    Exposure: Product categories sold into hospitals and specialty procedures

  3. Reimbursement and coverage pressureImpact: HighLikelihood: Medium

    Customer purchasing decisions depend on third-party coverage and reimbursement levels.

    Exposure: Hospital and provider purchasing channels

  4. Cybersecurity and IT disruptionImpact: MediumLikelihood: Medium

    Operational systems support ordering, invoicing, shipping, and customer relationships.

    Exposure: Enterprise systems and third-party technology providers

  5. Foreign exchange and procurement policy riskImpact: MediumLikelihood: Low

    International sales and China procurement programs can affect pricing and margins.

    Exposure: Asia and other non-U.S. markets

Ask Clarifo about Teleflex Incorporated

Accounting

Judgemental items
Inventory valuation and obsolescence

Single-use devices and product line changes can create excess or obsolete inventory risk.

Impact: Can affect cost of goods sold and gross profit through reserve adjustments

Restructuring charges

Footprint realignment and integration plans create employee, relocation, and facility costs.

Impact: Affects operating expenses and period-to-period comparability

Foreign exchange derivatives

The company hedges foreign currency exposure tied to international operations and acquisitions.

Impact: Can create mark-to-market gains or losses in earnings or OCI

Acquisition accounting

Purchased businesses bring fair value step-ups, intangibles, and integration-related estimates.

Impact: Affects revenue mix, amortization expense, and goodwill/intangible balances

Product liability and warranty reserves

Medical devices can generate claims, recalls, and warranty obligations over time.

Impact: Can materially affect operating expense and contingent liabilities

Similar listed companies

Publicly listed companies with a comparable business focus.

Teledyne Technologies Incorporated

TDY · Search, Detection, Navigation, Guidance, Aeronautical Sys

IR-Med, Inc.

Electromedical & Electrotherapeutic Apparatus

Orthofix Medical Inc.

OFIX · Surgical & Medical Instruments & Apparatus

Terex Corporation

TEX · Industrial Trucks, Tractors, Trailors & Stackers

Stryker Corporation

SYK · Surgical & Medical Instruments & Apparatus

Medtronic plc

MDT · Electromedical & Electrotherapeutic Apparatus

Last updated: 24/09/2026

Teleflex Incorporated (TFX) Revenue, Earnings & Financials 2025 – Clarifo